Construction of a bivalent vaccine candidate against HAdV4/HAdV7 based on capsid-display strategy via Red-homologous recombination and counter-selection methodology

MLA

Peng Wang, et al. “Construction of a Bivalent Vaccine Candidate against HAdV4/HAdV7 Based on Capsid-Display Strategy via Red-Homologous Recombination and Counter-Selection Methodology.” Biosafety and Health, vol. 6, no. 2, Apr. 2024, pp. 70–79. EBSCOhost, https://doi.org/10.1016/j.bsheal.2024.02.001.

APA

Peng Wang, Yunting Shao, Xichun Yang, Wenning Zhang, Jianguang Zhou, Fang Huang, Shuang Liu, Jiping Zheng, Chengjun Wu, & Shanhu Li. (2024). Construction of a bivalent vaccine candidate against HAdV4/HAdV7 based on capsid-display strategy via Red-homologous recombination and counter-selection methodology. Biosafety and Health, 6(2), 70–79. https://doi.org/10.1016/j.bsheal.2024.02.001

Chicago

Peng Wang, Yunting Shao, Xichun Yang, Wenning Zhang, Jianguang Zhou, Fang Huang, Shuang Liu, Jiping Zheng, Chengjun Wu, and Shanhu Li. 2024. “Construction of a Bivalent Vaccine Candidate against HAdV4/HAdV7 Based on Capsid-Display Strategy via Red-Homologous Recombination and Counter-Selection Methodology.” Biosafety and Health 6 (2): 70–79. doi:10.1016/j.bsheal.2024.02.001.